Submissions are open for a Health Economics Review collection on the pharmacoeconomics of vaccines: Advancing cost-effectiveness and access in global immunization strategies

Health Economics Review is calling for submissions to our Collection on The Pharmacoeconomics of Vaccines, with a deadline of December 22, 2025. The editor this collection is Wenxi Tang, PhD, China Pharmaceutical University, China.

Scope and submissions

• Cost-effectiveness analyses (CEA) and budget impact models of new and existing vaccines
• Pricing strategies and market dynamics affecting vaccine affordability and accessibility
• Economic evaluations of novel immunization technologies and delivery systems
• The role of Pharmacoeconomics in vaccine policy-making and reimbursement decisions
• Societal and indirect cost benefits of immunization programs
• Economic modeling approaches to assess vaccine interventions in different healthcare settings
• Comparative analyses of vaccine funding strategies in low-, middle-, and high-income countries
• Value-based assessment of a vaccine
• Other challenges (e.g. in regulatory science, expanding the National Immunization Program, adjuvant technologies, Real World Evidence bridging clinical trials and policy, hesitancy) related to vaccine (e.g. combined vaccine, polyvalent vaccine).

 Thumbnail image credit: Shutterstock / Lightspring